Search hospitals > Alberta > CALGARY
Novartis Investigative Site
Claim this profileCALGARY, Alberta T2N 4N2
Conducts research for Breast Cancer
Conducts research for Cancer
Conducts research for Renal Cell Carcinoma
Conducts research for Kidney Cancer
Conducts research for Retinal Vein Occlusion
64 reported clinical trials
0 medical researchers
Summary
Novartis Investigative Site is a medical facility located in CALGARY, Alberta. This center is recognized for care of Breast Cancer, Cancer, Renal Cell Carcinoma, Kidney Cancer, Retinal Vein Occlusion and other specialties. Novartis Investigative Site is involved with conducting 64 clinical trials across 85 conditions. There are 0 research doctors associated with this hospital, such as .Area of expertise
1Breast Cancer
ER positive
PR positive
HER2 negative
2Cancer
Stage IV
Top PIs
Clinical Trials running at Novartis Investigative Site
Chronic Urticaria
Cardiovascular Disease
Breast Cancer
Hives
Atherosclerosis
Long-term Remibrutinib
for Chronic Hives
This trial tests remibrutinib, a medication for adults with chronic hives not helped by standard treatments. It aims to see if remibrutinib can reduce symptoms by blocking signals that cause hives. Remibrutinib is a highly selective, oral medication that has shown promising efficacy and safety in treating chronic spontaneous urticaria.
Recruiting1 award Phase 34 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Novartis Investigative Site?
Novartis Investigative Site is a medical facility located in CALGARY, Alberta. This center is recognized for care of Breast Cancer, Cancer, Renal Cell Carcinoma, Kidney Cancer, Retinal Vein Occlusion and other specialties. Novartis Investigative Site is involved with conducting 64 clinical trials across 85 conditions. There are 0 research doctors associated with this hospital, such as .